Physician's Weekly Podcast

Enhertu for Brain Metastases in HER2+ Breast Cancer

November 10, 2021 Physician's Weekly Season 1 Episode 30
Physician's Weekly Podcast
Enhertu for Brain Metastases in HER2+ Breast Cancer
Show Notes

Welcome to this episode of Physician’s Weekly Podcast. My name is Dr Rachel Giles, from Medicom Medical Publishers, in collaboration with Physician’s Weekly. We have 3 fantastic in-depth interviews for you this week. 

In this 30th episode of the Physician’s Weekly Podcast, we speak with Dr Raman Muthsamy from UCLA, about a surgery-free and medicine-free approach to treat gastroesophageal reflux disorder (GERD), called transoral incisionless fundoplication (TIF) which can have durable results. 

Also in this episode, we speak with our regular contributor who goes by the pseudonym Dr MedLaw, about what a “jury of peers” might mean for a doctor testifying. As she points out, it will be unlikely that there will be anyone with medical knowledge on that jury, so what then?

But first, Physician’s Weekly speaks with Dr Rupert Bartsch from Vienna, Austria about their recently presented research in treating brain metastases in HER2-positive breast cancer with antibody-drug conjugate trastuzumab deruxtecan. This is our last segment on breast cancer in recognition of October being Breast Cancer Awareness Month. 

Enjoy listening!